MAPT and Alzheimer disease: As the aggregation of tau into paired helical filaments is also driven by β-sheet fibrillation [28], we hypothesized that YIAD002 may have additional inhibitory functions against tau aggregation, providing stronger resistance to AD pathology progression than YIAD001 in vivo.